4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MATTERHORN: Efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer - A randomized, double-blind, placebo-controlled, phase 3 study
    Meeting Abstract

    Janjigian, Y. Y.; Van Cutsem, E.; Muro, K.; Wainberg, Z. A.; Al-Batran, S. E.; Hyung, W. J.; Molena, D.; Evans, B.; Ruscica, D.; Robbins, S. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Genetic predictor of severe sorafenib-induced diarrhea and hand-foot syndrome (HFS)
    Meeting Abstract

    Quintanilha, J. C. F.; Geyer, S. M.; Wang, J.; Etheridge, A.; Denning, S.; Racioppi, A.; Hammond, K.; Crona, D.; Pena, C. E.; Jacobson, S. B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • T-cell receptor pharmacodynamics associated with survival and response to tremelimumab (T) in combination with durvalumab (D) in patients (pts) with unresectable hepatocellular carcinoma (uHCC)
    Meeting Abstract

    McCoon, P.; Lee, Y. S.; Kelley, R. K.; Guthrie, V. B.; Wu, S.; Bien, S. A.; Negro, A.; He, P.; Kurland, J.; Barrett, J. C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part B (pembrolizumab plus chemotherapy)
    Meeting Abstract

    Chan, J. A.; Raj, N. P.; Aggarwal, R. R.; Calabrese, S.; DeMore, A.; Dhawan, M. S.; Fattah, D.; Fong, L.; Grabowsky, J.; Hope, T. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Computational extraction and analysis of de-identified medical records to characterize hyperammonemia in patients with fibrolamellar carcinoma (FLC)
    Meeting Abstract

    Zack, T.; Maisel, S.; O'Neill, A. F.; La Quaglia, M. P.; Herman, M.; Knox, J. J.; Yaqubie, A.; Venook, A. P.; Mayer, R. J.; Gordan, J. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • First-in-human phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study of oral GNS561, a palmitoyl-protein thioesterase 1 (PPT1) inhibitor, in patients with primary and secondary liver malignancies
    Meeting Abstract

    Harding, J. J.; Awada, A.; Decaens, T.; Roth, G.; Merle, P.; Kotecki, N.; Dreyer, C.; Ansaldi, C.; Rachid, M.; Mezouar, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Real-world overall survival of patients diagnosed with recurrent versus de novo metastatic pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    O'Reilly, E. M.; Yu, K. H.; Lamarre, N.; Surinach, A.; Cockrum, P.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Disparity between the use of postoperative psychosocial and physical services among older adults with head and neck cancer
    Meeting Abstract

    Raab, G. T.; Restifo, D.; Tin, A. L.; Zakeri, K.; Shahrokni, A.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • BRCA reversion mutations in a pan-cancer cohort to reveal BRCA-dependence in select noncanonical BRCA-mutant histologies
    Meeting Abstract

    Murciano-Goroff, Y. R.; Schram, A. M.; Rosen, E.; Janjigian, Y. Y.; Berger, M. F.; Donoghue, M.; Bandlamudi, C.; Drilon, A. E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Disparities in end-of-life inpatient care received by patients with metastatic cancer, 2010 to 2017
    Meeting Abstract

    Deeb, S.; Chino, F.; Diamond, L.; Tao, A.; Aragones, A.; Shahrokni, A.; Yerramilli, D.; Gillespie, E. F.; Tsai, C. J.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save